GAMMA Investing’s Artiva Biotherapeutics ARTV Stock Holding History

GAMMA Investing’s Portfolio ARTV Stock Details ARTV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$3.54K	Buy	+497	New	+$5.01K	﹤0.01%	3780
2025 Q1	–	Sell	-15	Closed	-$151	–	3894
2024 Q4	$151	Buy	+15	New	+$180	﹤0.01%	3731

Other funds holding ARTV

Bailard Foster City, California $4.94B AUM 25.15% 1-Year Est. Return

Eastern Bank Boston, Massachusetts $6.58B AUM 23.57% 1-Year Est. Return

GAMMA Investing's ARTV Position: Q3 2026 in Review

GAMMA Investing opened a new position in Artiva Biotherapeutics (ARTV) in Q3 2026: 497 shares worth $3.54K. The stake represents ﹤0.01% of the portfolio and ranks #3780 among its holdings. This is a return to the name: GAMMA Investing previously reported a position in ARTV as recently as Q4 2024.

GAMMA Investing first reported a position in ARTV in Q4 2024 and has held it in 2 quarters since. 3 funds tracked by Wall St. Rank hold ARTV as of Q3 2026.

GAMMA Investing held 497 shares of Artiva Biotherapeutics worth $3.54K as of Q3 2026.
Artiva Biotherapeutics was a new GAMMA Investing position in Q3 2026.
Artiva Biotherapeutics made up ﹤0.01% of GAMMA Investing's portfolio in Q3 2026, its #3780 holding.
GAMMA Investing first reported a position in Artiva Biotherapeutics in Q4 2024 and has held it in 2 quarters since.
3 funds tracked by Wall St. Rank held Artiva Biotherapeutics as of Q3 2026.

Based on GAMMA Investing's 13F filing for Q3 2026, filed 8 Oct 2026.